357 related articles for article (PubMed ID: 25311381)
1. Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile.
Siddiqui MS; Fuchs M; Idowu MO; Luketic VA; Boyett S; Sargeant C; Stravitz RT; Puri P; Matherly S; Sterling RK; Contos M; Sanyal AJ
Clin Gastroenterol Hepatol; 2015 May; 13(5):1000-8.e3. PubMed ID: 25311381
[TBL] [Abstract][Full Text] [Related]
2. Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD.
Bril F; Sninsky JJ; Baca AM; Superko HR; Portillo Sanchez P; Biernacki D; Maximos M; Lomonaco R; Orsak B; Suman A; Weber MH; McPhaul MJ; Cusi K
J Clin Endocrinol Metab; 2016 Feb; 101(2):644-52. PubMed ID: 26672634
[TBL] [Abstract][Full Text] [Related]
3. Association between high-normal levels of alanine aminotransferase and risk factors for atherogenesis.
Siddiqui MS; Sterling RK; Luketic VA; Puri P; Stravitz RT; Bouneva I; Boyett S; Fuchs M; Sargeant C; Warnick GR; Grami S; Sanyal AJ
Gastroenterology; 2013 Dec; 145(6):1271-9.e1-3. PubMed ID: 23973920
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein Profiles in Class III Obese Caucasian and African American Women with Nonalcoholic Fatty Liver Disease.
Garcia AE; Kasim N; Tamboli RA; Gonzalez RS; Antoun J; Eckert EA; Marks-Shulman PA; Dunn J; Wattacheril J; Wallen T; Abumrad NN; Flynn CR
PLoS One; 2015; 10(11):e0142676. PubMed ID: 26599819
[TBL] [Abstract][Full Text] [Related]
5. De novo hepatic steatosis drives atherogenic risk in liver transplantation recipients.
Idowu MO; Chhatrala R; Siddiqui MB; Driscoll C; Stravitz RT; Sanyal AJ; Bhati C; Sargeant C; Luketic VA; Sterling RK; Contos M; Matherly S; Puri P; Siddiqui MS
Liver Transpl; 2015 Nov; 21(11):1395-402. PubMed ID: 26228654
[TBL] [Abstract][Full Text] [Related]
6. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M
J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071
[TBL] [Abstract][Full Text] [Related]
7. Discordant association of nonalcoholic fatty liver disease with lipoprotein(a) and markers of atherogenic dyslipidemia.
Mehta A; Lee TB; Alebna P; Grandhi GR; Dixon DL; Salloum FN; Sanyal AJ; Siddiqui MS
J Clin Lipidol; 2023; 17(6):828-833. PubMed ID: 37957050
[TBL] [Abstract][Full Text] [Related]
8. Association between small dense LDL levels and hepatic fibrosis in patients with nonalcoholic fatty liver disease.
Young Kim S; Mun S; Yu JH; Jin YJ; Ju Suh Y; Cho SH; Lee JW
Medicine (Baltimore); 2022 Sep; 101(37):e30527. PubMed ID: 36123875
[TBL] [Abstract][Full Text] [Related]
9. Irisin in patients with nonalcoholic fatty liver disease.
Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
[TBL] [Abstract][Full Text] [Related]
10. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
[TBL] [Abstract][Full Text] [Related]
11. Relationship between noninvasive scores of nonalcoholic fatty liver disease and nuclear magnetic resonance lipoprotein abnormalities: A focus on atherogenic dyslipidemia.
Amor AJ; Pinyol M; Solà E; Catalan M; Cofán M; Herreras Z; Amigó N; Gilabert R; Sala-Vila A; Ros E; Ortega E
J Clin Lipidol; 2017; 11(2):551-561.e7. PubMed ID: 28502513
[TBL] [Abstract][Full Text] [Related]
12. The inflamed liver and atherosclerosis: a link between histologic severity of nonalcoholic fatty liver disease and increased cardiovascular risk.
Alkhouri N; Tamimi TA; Yerian L; Lopez R; Zein NN; Feldstein AE
Dig Dis Sci; 2010 Sep; 55(9):2644-50. PubMed ID: 19960252
[TBL] [Abstract][Full Text] [Related]
13. Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease.
Sonmez A; Nikolic D; Dogru T; Ercin CN; Genc H; Cesur M; Tapan S; Karslioğlu Y; Montalto G; Banach M; Toth PP; Bagci S; Rizzo M
J Clin Lipidol; 2015; 9(4):576-82. PubMed ID: 26228676
[TBL] [Abstract][Full Text] [Related]
14. Association of nonalcoholic fatty liver disease with cardiovascular risk factors in obese adolescents: the role of interdisciplinary therapy.
Sanches PL; de Piano A; Campos RM; Carnier J; de Mello MT; Elias N; Fonseca FA; Masquio DC; da Silva PL; Corgosinho FC; Tock L; Oyama LM; Tufik S; Dâmaso AR
J Clin Lipidol; 2014; 8(3):265-72. PubMed ID: 24793347
[TBL] [Abstract][Full Text] [Related]
15. Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease.
Jiang ZG; Tapper EB; Connelly MA; Pimentel CF; Feldbrügge L; Kim M; Krawczyk S; Afdhal N; Robson SC; Herman MA; Otvos JD; Mukamal KJ; Lai M
Liver Int; 2016 Aug; 36(8):1213-20. PubMed ID: 26815314
[TBL] [Abstract][Full Text] [Related]
16. Association Between Lipoprotein Particles and Atherosclerotic Events in Nonalcoholic Fatty Liver Disease.
Patel S; Siddiqui MB; Roman JH; Zhang E; Lee E; Shen S; Faridnia M; Mintini RJ; Boyett S; Idowu MO; Sanyal AJ; Luketic VA; Siddiqui MS
Clin Gastroenterol Hepatol; 2021 Oct; 19(10):2202-2204. PubMed ID: 33007508
[TBL] [Abstract][Full Text] [Related]
17. Correlation between the small dense LDL level and nonalcoholic fatty liver disease: Possibility of a new biomarker.
Hwang HW; Yu JH; Jin YJ; Suh YJ; Lee JW
Medicine (Baltimore); 2020 Jul; 99(28):e21162. PubMed ID: 32664153
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein metabolism, dyslipidemia, and nonalcoholic fatty liver disease.
Cohen DE; Fisher EA
Semin Liver Dis; 2013 Nov; 33(4):380-8. PubMed ID: 24222095
[TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis.
DeFilippis AP; Blaha MJ; Martin SS; Reed RM; Jones SR; Nasir K; Blumenthal RS; Budoff MJ
Atherosclerosis; 2013 Apr; 227(2):429-36. PubMed ID: 23419204
[TBL] [Abstract][Full Text] [Related]
20. Interpreting lipoproteins in nonalcoholic fatty liver disease.
Nemes K; Åberg F
Curr Opin Lipidol; 2017 Aug; 28(4):355-360. PubMed ID: 28441156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
